Trial Profile
Linezolid in patients with linezolid-nonsusceptible enterococci (LNSE), linezolid-susceptible enterococci (LSE) and controls with no enterococcal infection : A retrospective analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2016
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Enterococcal infections
- Focus Adverse reactions; Therapeutic Use
- 16 Nov 2016 New trial record